Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

KNSA - Kiniksa Pharmaceuticals International Plc. - Ordinary Shares - Class A


IEX Last Trade
26.75
-0.010   -0.037%

Share volume: 227,263
Last Updated: Fri 30 Aug 2024 09:59:54 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%

$26.76
-0.01
-0.04%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
9%
Profitability 2%
Dept financing 4%
Liquidity 71%
Performance 0%
Company vs Stock growth
vs
Performance
5 Days
-2.34%
1 Month
0.98%
3 Months
48.56%
6 Months
48.56%
1 Year
48.56%
2 Year
48.56%
Key data
Stock price
$26.75
P/E Ratio 
0.00
DAY RANGE
N/A - N/A
EPS 
$0.00
52 WEEK RANGE
$17.38 - $27.92
52 WEEK CHANGE
$0.49
MARKET CAP 
1.086 B
YIELD 
N/A
SHARES OUTSTANDING 
40.609 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/29/2024
BETA 
2.45
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$239,879
AVERAGE 30 VOLUME 
$289,671
Company detail
CEO:
Region: US
Website:
Employees: 0
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Recent news